Krzysztof Kopeć:
According to the amended reimbursement law, as of November 1, 2023, patients should pay less at pharmacies for reimbursed drugs made in Poland or from Polish ingredients. Meanwhile, to date, the health ministry has not published a list of reimbursable drugs containing the products covered by the reduction. So who, and in whose interest, is blocking the provisions of the law causing patients to lose the savings in drug spending guaranteed to them by law - several million every month?
Drug shortages
In recent years, the supply of medicines of fundamental importance to health has been repeatedly disrupted throughout the EU. The years-long process of administratively lowering their prices, which in Poland today are among the lowest in the EU, and the lack of a mechanism that can contribute to increasing pharmaceutical production - have made the production of the cheapest drugs hardly profitable. Only 1/3 of reimbursed drugs are produced in Poland.
Therefore, the mechanisms in the Reimbursement Law for increasing domestic production must be implemented and expanded. Reimbursement preferences sh...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
